IGF2 and cardiac hypertrophy: Additionally, on average, hiPSC-CM lacking HO-1 were 13.4% (±4.8%) bigger than hiPSC-CM WT (Figure 10C); this observation is also supported by increased expression of IGF2, a key factor involved in cardiac hypertrophy (Figure 10D).